Which has stronger valuation & earnings, AIMDW or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ainos $18.11K N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is AIMDW or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets Ainos N/A N/A N/A XOMA N/A N/A N/A

Which has stronger valuation and earnings, XOMAP or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio XOMA $7.65M N/A N/A N/A N/A Alvotech $559.42M N/A N/A N/A N/A

Is XOMAP or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets XOMA N/A N/A N/A Alvotech N/A N/A N/A

Which has higher earnings & valuation, ARAV or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A XOMA $7.65M N/A N/A N/A N/A

Is ARAV or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A XOMA N/A N/A N/A

Which has stronger valuation and earnings, ACABW or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is ACABW or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets Atlantic Coastal Acquisition Corp. II N/A N/A N/A XOMA N/A N/A N/A

Which has higher earnings and valuation, BFRIW or XOMAP?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A XOMA $7.65M N/A N/A N/A N/A

Is BFRIW or XOMAP more profitable?

Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A XOMA N/A N/A N/A

XOMA (XOMAP) Competitors

$25.42 -0.09 (-0.35%)

As of 10:13 AM Eastern

Compare

XOMAP vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy XOMA stock or one of its competitors? MarketBeat compares XOMA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with XOMA include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does XOMA compare to Ainos?

Ainos (NASDAQ:AIMDW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

In the previous week, XOMA had 1 more articles in the media than Ainos. MarketBeat recorded 3 mentions for XOMA and 2 mentions for Ainos. XOMA's average media sentiment score of 1.44 beat Ainos' score of 0.93 indicating that XOMA is being referred to more favorably in the news media.

Company	Overall Sentiment
Ainos	Positive
XOMA	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ainos	$18.11K	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Ainos	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Summary

XOMA beats Ainos on 3 of the 3 factors compared between the two stocks.

How does XOMA compare to Alvotech?

XOMA (NASDAQ:XOMAP) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

In the previous week, XOMA had 2 more articles in the media than Alvotech. MarketBeat recorded 3 mentions for XOMA and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.89 beat XOMA's score of 1.44 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
XOMA	Positive
Alvotech	Very Positive

Company	Net Margins	Return on Equity	Return on Assets
XOMA	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XOMA	$7.65M	N/A	N/A	N/A	N/A
Alvotech	$559.42M	N/A	N/A	N/A	N/A

Summary

Alvotech beats XOMA on 2 of the 3 factors compared between the two stocks.

How does XOMA compare to Aravive?

Aravive (NASDAQ:ARAV) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, XOMA had 3 more articles in the media than Aravive. MarketBeat recorded 3 mentions for XOMA and 0 mentions for Aravive. XOMA's average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that XOMA is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
XOMA	Positive

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

Summary

XOMA beats Aravive on 3 of the 5 factors compared between the two stocks.

How does XOMA compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and XOMA (NASDAQ:XOMAP) are both pharmaceutical products companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

In the previous week, XOMA had 3 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 3 mentions for XOMA and 0 mentions for Atlantic Coastal Acquisition Corp. II. XOMA's average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that XOMA is being referred to more favorably in the news media.

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
XOMA	Positive

Summary

XOMA beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does XOMA compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
XOMA	N/A	N/A	N/A

In the previous week, XOMA had 2 more articles in the media than Biofrontera. MarketBeat recorded 3 mentions for XOMA and 1 mentions for Biofrontera. Biofrontera's average media sentiment score of 1.87 beat XOMA's score of 1.44 indicating that Biofrontera is being referred to more favorably in the media.

Company	Overall Sentiment
Biofrontera	Very Positive
XOMA	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
XOMA	$7.65M	N/A	N/A	N/A	N/A

Summary

Biofrontera beats XOMA on 2 of the 3 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XOMAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XOMAP vs. The Competition

Export

Metric	XOMA	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$463.60M	$6.49B	$12.31B
Dividend Yield	9.29%	3.88%	2.67%	5.66%
P/E Ratio	N/A	3.17	24.05	24.76
Price / Sales	N/A	6,514.93	542.61	168.32
Price / Cash	N/A	13.13	27.48	37.92
Price / Book	N/A	90.26	10.69	6.90
Net Income	N/A	-$96.07M	$3.57B	$337.45M
7 Day Performance	-0.39%	0.07%	1.56%	2.84%
1 Month Performance	-0.39%	-0.35%	2.49%	4.78%
1 Year Performance	-1.82%	56.78%	26.51%	33.08%

XOMA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XOMAP XOMA	N/A	$25.42 -0.4%	N/A	-1.6%	$0.00	$7.65M	N/A	10	Positive News Dividend Announcement
AIMDW Ainos	N/A	$0.12 -2.0%	N/A	+25.5%	$0.00	$18.11K	N/A	40	Gap Down
ALVOW Alvotech	N/A	$0.18 -13.0%	N/A	-83.2%	$0.00	$586.32M	N/A	4	Positive News Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	-87.6%	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XOMAP) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

XOMA (XOMAP) Competitors